drugset / Trial / NCT00754130

MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).

NCT00754130

Phase 1 Completed 16 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-0941 in Japanese patients with Type 2 Diabetes.

Timeline

Start
2008-09
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-0941 Small molecule 5 mg
Subject MK-0941 Small molecule 10 mg
Subject MK-0941 Small molecule 20 mg
Subject MK-0941 Small molecule 40 mg